Mistras Group, Inc. (MG)
NYSEIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
$19.12+0.31%
Close 2026-09-04 · 1-day change
NYSEIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · MG
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on expanding revenue in Aerospace & Defense, Infrastructure, and Power Generation end markets to support overall growth.
Stated as a priority in 3 of last 3 quarters. Revenue increased from $169.0 million in 2026-Q1 to $193.1 million in 2026-Q2, driven by strong growth in Aerospace & Defense (+35.5% in 2026-Q1) and continued demand in Infrastructure and Power Generation. The trajectory is delivering with mid-single-digit revenue growth sustained over four consecutive quarters.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated neutral grew net income 51% of the time over the next year (vs 60% for the rest of the cohort, n=9249).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Demand growth in Infrastructure, Power Generation, and Aerospace & Defense end markets”
“Strong growth of 35.5% in Aerospace & Defense and growth in Infrastructure and Power Generation”
“Growth in strategic markets including Aerospace & Defense and Infrastructure”
Increase Adjusted EBITDA and operating income through operational efficiencies and margin expansion.
Stated as a priority in 3 of last 3 quarters. Adjusted EBITDA increased from $14.3 million in 2026-Q1 to $25.8 million in 2026-Q2, with operating income rising from $4.7 million to $12.9 million. Margins expanded modestly, indicating delivering progress on profitability and operational efficiency.
“Adjusted EBITDA of $25.8 million, an increase of 7.0%, margin up 30 basis points”
“Adjusted EBITDA of $14.3 million, an increase of 18.7%, margin up 110 basis points”
“Adjusted EBITDA margin improvement and profitability focus”
Focus on generating meaningful free cash flow and using residual cash to reduce debt and invest in growth.
Stated as a priority in 3 of last 3 quarters. Net cash from operations improved from $2.8 million in 2026-Q1 to $17.7 million in first half 2026, while gross debt declined from $178.0 million at 2025-Q4 to $172.1 million at 2026-Q2. The trajectory shows delivering progress on cash flow improvement and debt reduction.
“Net cash provided by operating activities was $17.7 million in first half 2026”
“Net cash from operations was $2.8 million in 2026-Q1”
“Gross debt was $178.0 million as of December 31, 2025”
Invest in expanding capacity and throughput in in-lab testing operations with a focus on automation to meet demand.
Stated as a priority in 2 of last 3 quarters. Management emphasized investments to expand capacity and automation in in-lab testing operations to meet demand. No specific capacity or throughput metrics disclosed yet, indicating early-stage or ongoing execution.
“Investing meaningfully to expand capacity in in-lab testing with focus on automation”
“Committed to investing in expanding capacity and throughput to capitalize on demand”
Use residual free cash flow to pay down debt to targeted leverage and invest in higher growth, higher value areas.
Stated as a priority in 2 of last 3 quarters. Management reiterated focus on disciplined capital allocation to reduce leverage to 2x by end of 2026 and invest in growth. Financials show gross debt declining and improving cash flow, consistent with this priority.
“Capital allocation strategy remains focused on paying down debt to 2x leverage and investing in growth”
“Committed to using free cash flow to fund strategic capital expenditures and reduce debt”
Over the trailing year it converted -10.83x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
7 material management or governance events in the past 24 months, led by executive changes. Historically, Industrials names rated stable grew net income 55% of the time over the next year (vs 58% for the rest of the cohort, n=2546).
Not investment advice. As of 2026-09-04.